MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$453,816K
EPS
-$2.29
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue
-0* --
Research and development
343,970 254,651* 262,506 224,134
General and administrative
101,252 55,023* 52,763 40,580
Total operating expenses
445,222 309,673* 315,269 264,714
Loss from operations
-445,222 -309,673* -315,269 -264,714
Interest income
19,508 8,142* 22,083 22,404
Interest and other income (expense), net
----899
Interest expense
12,197 -10,053* 11,428 -
Change in fair value of warrant liability and contingent earn-out shares
--7,603* -592 -4,578
Change in fair value of warrant liability
15,788 ---
Other expense, net
-9* --
Other income (expense), net
117 -0 -
Total non-operating income (expense), net
-8,594 10,583* 10,063 16,927
Loss before income taxes
-453,816 -299,090* -305,206 -247,787
Benefit from income taxes
-0* --
Net loss
-453,816 -299,090* -305,206 -247,787
Unrealized loss on investments, net
--3,526* 1,814 -
Comprehensive loss
--302,616 -303,392 -
Basic EPS
-2.29 -1.571 -1.61 -1.31
Diluted EPS
-2.29 -1.571 -1.61 -1.31
Basic Average Shares
198,098,047 192,572,612 189,231,562 188,583,288
Diluted Average Shares
198,098,047 192,572,612 189,231,562 188,583,288
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$453,816K Loss before incometaxes-$453,816K Loss from operations-$445,222K Total non-operatingincome (expense), net-$8,594K Interest income$19,508K Total operatingexpenses$445,222K Change in fair value ofwarrant liability$15,788K Interest expense$12,197K Other income(expense), net$117K Research and development$343,970K General andadministrative$101,252K

Revolution Medicines, Inc. (RVMD)

Revolution Medicines, Inc. (RVMD)